Literature DB >> 26026928

Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management.

Louise R A Olde Nordkamp1, Tom F Brouwer1, Craig Barr2, Dominic A M J Theuns3, Lucas V A Boersma4, Jens B Johansen5, Petr Neuzil6, Arthur A M Wilde1, Nathan Carter7, Michael Husby7, Pier D Lambiase8, Reinoud E Knops9.   

Abstract

BACKGROUND: The entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) eliminates the need for transvenous leads, and therefore has the potential to improve lead-longevity and reduce lead-related complications. The S-ICD has a morphology-based sensing algorithm of which inappropriate shocks have been reported.
METHODS: We analyzed the incidence, predictors and management of inappropriate shocks in the EFFORTLESS S-ICD Registry, which collects S-ICD implantation information and follow-up data from clinical centers in Europe and New Zealand.
RESULTS: During a follow-up of 21 ± 13 months, 48 out of 581 S-ICD patients (71% male, age 49 ± 18 years) experienced 101 inappropriate shocks (8.3%). The most common cause was cardiac signal oversensing (73%), such as T-wave oversensing. Eighteen shocks (18%) were due to supraventricular tachycardias (SVT), of which 15 occurred in the shock-only zone. Cox-proportional hazard modeling using time-dependent covariates demonstrated that patients with a history of atrial fibrillation (HR 2.4) and patients with hypertrophic cardiomyopathy (HR 4.6) had an increased risk for inappropriate shocks, while programming the primary vector for sensing (from xyphoid to V6) reduced the risk. Reprogramming or optimization of SVT treatment after the first clinical event of inappropriate shock was successful in preventing further inappropriate shocks for cardiac oversensing and SVT events.
CONCLUSIONS: Inappropriate shocks, mainly due to cardiac oversensing, occurred in 8.3% of the S-ICD patients. Patients with hypertrophic cardiomyopathy or a history of atrial fibrillation were at increased risk, warranting specific attention for sensing and programming in this population.
Copyright © 2015. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Hypertrophic cardiomyopathy; Implantable cardioverter-defibrillator; Inappropriate shocks

Mesh:

Year:  2015        PMID: 26026928     DOI: 10.1016/j.ijcard.2015.05.135

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  38 in total

Review 1.  Lead or be led: an update on leadless cardiac devices for general physicians.

Authors:  Benedict M Wiles; Paul R Roberts
Journal:  Clin Med (Lond)       Date:  2017-02       Impact factor: 2.659

2.  Inappropriate shock from myopotentials due to subcutaneous defibrillator (S-ICD) movement confirmed on fluoroscopy with subsequent device pocket revision.

Authors:  David Chieng; Brock Stewart; Vince Paul
Journal:  J Interv Card Electrophysiol       Date:  2018-07-06       Impact factor: 1.900

Review 3.  [Leadless pacemakers and subcutaneously implantable cardioverter defibrillators].

Authors:  C Stellbrink; B Hansky; D Meyer Zu Vilsendorf
Journal:  Internist (Berl)       Date:  2018-10       Impact factor: 0.743

4.  Reduction of inappropriate implantable cardioverter-defibrillator therapies using enhanced supraventricular tachycardia discriminators: the ReduceIT study.

Authors:  Johann Christoph Geller; Armin Wöhrle; Mathias Busch; Albrecht Elsässer; Thomas Kleemann; Frank Birkenhauer; Peter Bramlage; Christian Veltmann
Journal:  J Interv Card Electrophysiol       Date:  2020-07-14       Impact factor: 1.900

5.  Influence of Multimorbidity on Burden and Appropriateness of Implantable Cardioverter-Defibrillator Therapies.

Authors:  Alexandra M Hajduk; Jerry H Gurwitz; Grace Tabada; Frederick A Masoudi; David J Magid; Robert T Greenlee; Sue Hee Sung; Andrea E Cassidy-Bushrow; Taylor I Liu; Kristi Reynolds; David H Smith; Frances Fiocchi; Robert Goldberg; Thomas M Gill; Nigel Gupta; Pamela N Peterson; Claudio Schuger; Humberto Vidaillet; Stephen C Hammill; Heather Allore; Alan S Go
Journal:  J Am Geriatr Soc       Date:  2019-03-20       Impact factor: 5.562

Review 6.  [Management of inappropriate shocks/T-wave-oversensing in S-ICD®-patients].

Authors:  Robert Larbig; Markus Bettin; Lukas J Motloch; Alicia Fischer; Niklas Bode; Gerrit Frommeyer; Florian Reinke; Andreas Loeher; Lars Eckardt; Julia Köbe
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-02-12

7.  Analysis of Screening Electrocardiogram for the Subcutaneous Defibrillator in Adults with Congenital Heart Disease.

Authors:  Vincent C Thomas; Mark Peterson; Martin McDaniel; Humberto Restrepo; Abraham Rothman; Amit Jain
Journal:  Pediatr Cardiol       Date:  2017-05-22       Impact factor: 1.655

8.  Feasibility of entirely subcutaneous ICD™ systems in patients with coronary artery disease.

Authors:  Kevin Willy; Markus Bettin; Florian Reinke; Nils Bögeholz; Christian Ellermann; Benjamin Rath; Patrick Leitz; Julia Köbe; Lars Eckardt; Gerrit Frommeyer
Journal:  Clin Res Cardiol       Date:  2019-03-21       Impact factor: 5.460

9.  The utility of routine clinical 12-lead ECG in assessing eligibility for subcutaneous implantable cardioverter defibrillator.

Authors:  Jason A Thomas; Erick Andres Perez-Alday; Christopher Hamilton; Muammar M Kabir; Eugene A Park; Larisa G Tereshchenko
Journal:  Comput Biol Med       Date:  2018-05-08       Impact factor: 4.589

10.  Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experience.

Authors:  Gerrit Frommeyer; Dirk G Dechering; Sven Zumhagen; Andreas Löher; Julia Köbe; Lars Eckardt; Florian Reinke
Journal:  Clin Res Cardiol       Date:  2015-08-02       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.